Lilly requests EMA to re-examine Alzheimer's drug recommendationL
Continue reading...
Lilly requests EMA to re-examine Alzheimer’s drug recommendation
Lilly requests EMA to re-examine Alzheimer's drug recommendation
 Eli Lilly (LLY.N), opens new tab has requested Europe's medicines regulator to re-examine its opinion on the company's Alzheimer's...